Glucose-6-phosphate dehydrogenase deficiency in two returning operation Iraqi freedom soldiers who developed hemolytic anemia while receiving primaquine prophylaxis for malaria

Military Medicine

Volumn 170, Issue 4, 2005, Pages 273-276

  Carr Jr , Marcus E ^a,b   Fandre, Matthew N ^a   Oduwa, Felix O ^a  

^a CARL R DARNALL ARMY MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; FOLIC ACID; IBUPROFEN; PREDNISONE; PRIMAQUINE; PROMETHAZINE;

ADULT; ANAMNESIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEADACHE; HEMOLYTIC ANEMIA; HUMAN; MALARIA; MALE; PLASMODIUM OVALE; PLASMODIUM VIVAX; SOLDIER;

EID: 17444387429     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.170.4.273     Document Type: Article

References (17)

1. Ali NA, al-Naama LM, Khalid LO: Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-D-phosphate dehydrogenase deficiency. East Mediterr Health J 1999; 5: 457-64.
2. Myat-Phone-Kyaw, Myint-Oo, Aung-Naing, Aye-Lwin-Htwe: The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar. Southeast Asian J Trop Med Public Health 1994; 25: 710-3.
3. Menendez Capote R, Diaz Perez L, Luzardo Suarez C: Hemolysis and primaquine treatment: preliminary report. Rev Cubana Med Trop 1994; 49: 136-8.
4. Menendez Capote R, Cana Lugo C, Fernandez Nunez A: Primaquine and travelers from the Arab world: a report and recommendations. Rev Cubana Med Trop 1995; 47: 221-3.
5. Hochstein P: Perspectives on hydrogen peroxide and drug-induced hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency. Free Radic Biol Med 1988; 5: 387-92.
6. Valentine WN, Tanaka KR, Paglia DE: Hemolytic anemias and erythrocyte enzymopathies. Ann Intern Med 1985; 103: 245-57.
7. Miwa S, Fujii H: Molecular aspects of erythroenzymopathies associated with hereditary hemolytic anemia. Am J Hematol 1985; 19: 293-305.
8. Fujii H, Miwa S: Recent progress in the molecular genetic analysis of erythroenzymopathy. Am J Hematol 1990; 34: 301-10.
9. Keskin N, Ozdes I, Keskin A, Acikbas I, Bagci H: Incidence and molecular analysis of glucose-6-phosphate dehydrogenase deficiency in the province of Denizli, Turkey. Med Sci Monit 2002; 8: CR453-6.
10. Beutler E: G6PD: population genetics and clinical manifestations. Blood Rev 1996; 10: 45-52.
11. May J, Meyer CG, Grossterlinden L, et al: Red cell glucose-6-phosphate dehydrogenase status and pyruvate kinase activity in a Nigerian population. Trop Med Int Health 2000; 5: 119-23.
12. Roth EF Jr, Raventos-Suarez C, Rinaldi A, Nagel RL: Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum. Proc Natl Acad Sci USA 1983; 80: 298-9.
13. Janney SK, Joist JJ, Fitch CD: Excess release of ferriheme in G6PD-deficient erythrocytes: possible cause of hemolysis and resistance to malaria. Blood 1986; 67: 331-3.
14. Kitayaporn D, Charoenlarp P, Pattaraarechachai J, Pholpoti T: G6PD deficiency and fava bean consumption do not produce hemolysis in Thailand. Southeast Asian J Trop Med Public Health 1991; 22: 176-82.
15. Arese P: Favism: a natural model for the study of hemolytic mechanisms. Rev Pure Appl Pharmacol Sci 1982; 3: 123-83.
16. Sarkar S, Prakash D, Marwaha RK, et al: Acute intravascular haemolysis in glucose-6-phosphate dehydrogenase deficiency. Ann Trop Paediatr 1993; 13: 391-4.
17. Morse EE: Toxic effects of drugs on erythrocytes. Ann Clin Lab Sci 1988; 18: 13-8.